» Articles » PMID: 28941026

Transcription Instability in High-risk Neuroblastoma is Associated with a Global Perturbation of Chromatin Domains

Overview
Journal Mol Oncol
Date 2017 Sep 24
PMID 28941026
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Chromosome instability has a pivotal role among the hallmarks of cancer, but its transcriptional counterpart is rarely considered a relevant factor in cell destabilization. To examine transcription instability (TIN), we first devised a metric we named TIN index and used it to evaluate TIN on a dataset containing more than 500 neuroblastoma samples. We found that metastatic tumors from high-risk (HR) patients are characterized by significantly different TIN index values compared to low/intermediate-risk patients. Our results indicate that the TIN index is a good predictor of neuroblastoma patient's outcome, and a related TIN index gene signature (TIN-signature) is also able to predict the neuroblastoma patient's outcome with high confidence. Interestingly, we find that TIN-signature genes have a strong positional association with superenhancers in neuroblastoma tumors. Finally, we show that TIN is linked to chromatin structural domains and interferes with their integrity in HR neuroblastoma patients. This novel approach to gene expression analysis broadens the perspective of genome instability investigations to include functional aspects.

Citing Articles

The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis.

Murray J, Valli E, Milazzo G, Mayoh C, Gifford A, Fletcher J Nat Commun. 2024; 15(1):5585.

PMID: 38992040 PMC: 11239676. DOI: 10.1038/s41467-024-49871-0.


Why Is Aneuploidy Associated with Favorable Outcome in Neuroblastoma?.

Tonini G Biomolecules. 2021; 11(8).

PMID: 34439783 PMC: 8391846. DOI: 10.3390/biom11081116.


MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment.

Garbati P, Barbieri R, Cangelosi D, Zanon C, Costa D, Eva A Biomedicines. 2020; 8(11).

PMID: 33153038 PMC: 7692293. DOI: 10.3390/biomedicines8110471.


Systematic computational identification of prognostic cytogenetic markers in neuroblastoma.

Qin C, He X, Zhao Y, Tong C, Zhu K, Sun Y BMC Med Genomics. 2019; 12(1):192.

PMID: 31831008 PMC: 6909636. DOI: 10.1186/s12920-019-0620-6.


Neuroblastoma by chance.

Tonini G J Cancer. 2019; 10(12):2601-2603.

PMID: 31258767 PMC: 6584915. DOI: 10.7150/jca.33291.

References
1.
Scaruffi P, Coco S, Cifuentes F, Albino D, Nair M, Defferrari R . Identification and characterization of DNA imbalances in neuroblastoma by high-resolution oligonucleotide array comparative genomic hybridization. Cancer Genet Cytogenet. 2007; 177(1):20-9. DOI: 10.1016/j.cancergencyto.2007.05.002. View

2.
Hnisz D, Abraham B, Lee T, Lau A, Saint-Andre V, Sigova A . Super-enhancers in the control of cell identity and disease. Cell. 2013; 155(4):934-47. PMC: 3841062. DOI: 10.1016/j.cell.2013.09.053. View

3.
Oberthuer A, Hero B, Berthold F, Juraeva D, Faldum A, Kahlert Y . Prognostic impact of gene expression-based classification for neuroblastoma. J Clin Oncol. 2010; 28(21):3506-15. DOI: 10.1200/JCO.2009.27.3367. View

4.
de Laat W, Duboule D . Topology of mammalian developmental enhancers and their regulatory landscapes. Nature. 2013; 502(7472):499-506. DOI: 10.1038/nature12753. View

5.
Mortusewicz O, Herr P, Helleday T . Early replication fragile sites: where replication-transcription collisions cause genetic instability. EMBO J. 2013; 32(4):493-5. PMC: 3579142. DOI: 10.1038/emboj.2013.20. View